Structural & Mechanism
33 entries.
-
Proline cis–trans isomerization: when two chromatographic peaks are one peptide
A proline-containing peptide can elute as two peaks of identical mass with no impurity present. What causes conformational doubling, and how to identify it.
-
Native chemical ligation: how long peptides get built when stepwise synthesis runs out of room
Stepwise chain assembly degrades with length. Chemoselective ligation joins purified fragments instead — and leaves a different impurity record behind.
-
Fmoc versus Boc solid-phase synthesis: how the protecting-group strategy shapes the final material
Two protection schemes build the same sequence by different chemistry. The choice propagates into the impurity fingerprint and the residual solvent profile.
-
Macrocyclization and conformational constraint in peptide research
Closing a peptide into a ring reshapes its conformational ensemble and protease susceptibility — and quietly disables several standard characterization methods.
-
Fatty acid acylation and albumin binding: the structural chemistry behind long-acting peptides
A gamma-Glu spacer, two ethylene glycol units and a C18 diacid turn a peptide with a two-minute half-life into one measured in days. Here is the chemistry.
-
Pyroglutamate formation: the N-terminal cyclization that hides in a −17 Da mass shift
N-terminal glutamine can cyclize to pyroglutamate, shifting mass by −17 Da and blocking the free amine. The mechanism, kinetics, and analytical signatures.
-
Disulfide scrambling: why two peptides with identical mass can be different molecules
Disulfide isomers share a sequence, a formula, and a mass. What separates them is connectivity — and most routine peptide identity testing cannot see it.
-
Racemization and chiral purity: the peptide impurity that is invisible to both HPLC and mass spectrometry
A D-amino acid impurity has the same mass as the target and often the same retention time. What racemization does to a peptide, and how it is measured.
-
Peptide aggregation: why soluble oligomers are invisible to a purity certificate
Aggregation removes peptide from solution without altering mass or covalent structure — which is exactly why RP-HPLC and mass spectrometry do not detect it.
-
Light exposure and peptide photodegradation: which residues absorb, and what happens next
Only a few amino acid residues absorb near-UV light, but their photochemistry drives most light-related peptide degradation. A look at the mechanisms.
-
Peptide solubility: isoelectric point, net charge, and why some sequences resist reconstitution
Solubility is a sequence property, not a quality defect. How isoelectric point, net charge, and hydrophobic patterning govern whether a peptide dissolves.
-
GLP-1/GIP/Glucagon: The tri-agonist and multi-agonist peptide landscape in 2026
The obesity and metabolic peptide research space has shifted decisively toward multi-receptor agonists. This overview covers every major dual, triple, and combination agonist currently in clinical development.
-
Retatrutide vs Tirzepatide: How triple- and dual-agonists differ
Retatrutide is a triple agonist at GLP-1, GIP, and glucagon receptors. Tirzepatide is a dual GLP-1/GIP agonist. This post explains what the third receptor changes about mechanism and metabolic effect.
-
What is Cagrilintide? An amylin analog research overview
Cagrilintide is a long-acting amylin analog studied for its effects on appetite regulation and glucose metabolism, most notably in combination with semaglutide (CagriSema). This overview covers its mechanism, pharmacology, and current research landscape.
-
GHRP-2 vs GHRP-6: A Growth Hormone Secretagogue Research Comparison
GHRP-2 and GHRP-6 are two of the founding members of the synthetic growth hormone-releasing peptide (GHRP) class — short peptide ghrelin-receptor agonists characterized in the late 1980s and early 1990s. Both bind the…
-
Liraglutide Research Overview: The Original Long-Acting GLP-1 Agonist
Liraglutide was the first long-acting glucagon-like peptide-1 (GLP-1) receptor agonist to be characterized at the molecular level, and remains the prototype research compound for studying acylation-mediated half-life…
-
The GLP-1 Research Landscape, Q2 2026
The incretin-axis research peptide category has expanded rapidly over the last five years. What was once a small set of GLP-1 receptor agonist research probes has grown into a multi-mechanism toolkit spanning…
-
SS-31 (Szeto-Schiller Peptide) Mechanism: Mitochondria-Targeted Tetrapeptide
SS-31 — also designated elamipretide in the development literature, and named for its developers Hazel Szeto and Peter Schiller — is a small synthetic tetrapeptide engineered to selectively concentrate at the inner…
-
Tesamorelin Research Overview: GHRH Analog Mechanism and Preclinical Findings
Tesamorelin is a synthetic stabilized analog of growth hormone-releasing hormone (GHRH) — specifically, the GHRH(1-44) full-length sequence modified by attachment of a trans-3-hexenoyl moiety to the N-terminal tyrosine.…
-
What is Survodutide? A GLP-1/Glucagon Dual Agonist Research Overview
Survodutide (development code BI 456906) is a synthetic dual-receptor research peptide engineered to simultaneously activate the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). In the…
-
MOTS-c: A Mitochondrial-Derived Peptide Research Overview
MOTS-c — “Mitochondrial Open Reading frame of the Twelve S rRNA type-c” — is a 16-amino-acid peptide encoded within the mitochondrial 12S ribosomal RNA gene. It is one of the most-studied members of the…
-
Sermorelin vs CJC-1295: A Research Comparison of GHRH Analogs
Sermorelin and CJC-1295 are both synthetic analogs of growth hormone-releasing hormone (GHRH), and both bind the same hypothalamic-pituitary GHRH receptor (GHRHR) to drive somatotroph signaling. The difference between…
-
Cagrilintide Mechanism and Amylin Biology: A Research Overview
Cagrilintide is a long-acting synthetic analog of human amylin — the pancreatic hormone co-secreted with insulin from β-cell granules in response to a glucose load. Where the incretin class (GLP-1, GIP) signals from the…
-
Tirzepatide Mechanism Deep-Dive: GLP-1/GIP Dual Agonism in Research Context
Tirzepatide is the prototype dual-incretin research peptide — a synthetic 39-amino-acid analog engineered to simultaneously activate the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic…
-
GHK vs GHK-Cu: What’s the Difference in the Research?
Few questions come up more often in the peptide research category than this one: are GHK and GHK-Cu the same thing, and if not, which one does the published literature actually describe? The two names are used interchangeably in marketing copy, in supplier listings, and even in some review articles.
-
BPC-157 vs. TB-500: A Research Comparison
BPC-157 and TB-500 are the two peptides most frequently compared in the tissue-repair and soft-tissue research literature.
-
Melanotan 2 and the Melanocortin Receptor Family: A Research Overview
Melanotan 2 (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH), the endogenous melanocortin-system peptide derived from proopiomelanocortin (POMC).
-
Sermorelin and the GHRH Analog Class: A Research Overview
Sermorelin is a synthetic 29-amino-acid peptide that corresponds to the first 29 residues of growth hormone-releasing hormone (GHRH), the endogenous hypothalamic peptide that stimulates somatotroph release of growth hormone (GH) from the anterior pituitary.
-
TB-500 (Thymosin Beta-4): A Research Overview of an Actin-Sequestering Peptide
TB-500 is a synthetic research peptide based on the 17-amino-acid active sequence of thymosin beta-4, a small actin-sequestering protein originally isolated from calf thymus in the early 1980s. The full-length parent molecule, thymosin beta-4, is the most abundant member of the b
-
Retatrutide vs. Semaglutide: A Research Comparison
Semaglutide and retatrutide are the two compounds most commonly compared in the current GLP-1 research literature, but the comparison is somewhat lopsided: semaglutide is an approved, marketed...
-
GHK-Cu: The Copper Peptide in Skin and Tissue Research
GHK-Cu — the copper-bound complex of the tripeptide glycyl-L-histidyl-L-lysine — is one of the most-studied small peptides in regenerative biology. Loren Pickart's 1973 isolation of the GHK...
-
BPC-157: A Complete Research Overview
BPC-157 — short for body protection compound 157, a pentadecapeptide first isolated from a fragment of human gastric juice protein — is one of the most-studied research peptides of the last twenty...
-
What Are Peptides? A Comprehensive Guide for Researchers
A detailed overview of peptides — what they are, how they differ from proteins, and why they are essential tools in modern scientific research.